Literature DB >> 10396030

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men.

K Krithivas1, S M Yurgalevitch, B A Mohr, C J Wilcox, S J Batter, M Brown, C Longcope, J B McKinlay, P W Kantoff.   

Abstract

In men over 30 years old, serum levels of testosterone (T) decrease with age. A shorter polymorphic CAG repeat length in exon 1 of the androgen receptor (AR) gene is associated with higher transcription activation by the AR. We determined the number of CAG repeats for 882 men aged between 40 and 70 years from the Massachusetts Male Aging Study (MMAS). MMAS is a population-based random sample survey of men for whom baseline (1987-1989, mean age 53+/-8 years) and follow-up (1995-1997, mean age 61+/-8 years) serum hormone levels were available. Multiple linear regression was used to determine if CAG repeat length would be predictive of hormone levels at follow-up. Hormone levels measured included T, free T, albumin-bound T, dihydrotestosterone (DHT), sex hormone-binding globulin (SHBG) and luteinizing hormone (LH). The CAG repeat length was significantly associated with T (P=0.041), albumin-bound T (P=0.025) and free T (P=0.003) when controlled for age, baseline hormone levels and anthropometrics. Follow-up levels of T decreased by 0.74%+/-0.36 per CAG repeat decrement. Likewise, the percentages of free and albumin-bound T decreased by 0.93%+/-0.31 and 0.71%+/-0.32 per CAG repeat decrement respectively. These results suggest that androgen levels may be modulated by AR genotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396030     DOI: 10.1677/joe.0.1620137

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  40 in total

1.  A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Authors:  Sara Lindström; Jing Ma; David Altshuler; Edward Giovannucci; Elio Riboli; Demetrius Albanes; Naomi E Allen; Sonja I Berndt; Heiner Boeing; H Bas Bueno-de-Mesquita; Stephen J Chanock; Alison M Dunning; Heather Spencer Feigelson; J Michael Gaziano; Christopher A Haiman; Richard B Hayes; Brian E Henderson; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Loic Le Marchand; Carmen Martínez; Kim Overvad; Afshan Siddiq; Meir Stampfer; Pär Stattin; Daniel O Stram; Michael J Thun; Dimitrios Trichopoulos; Rosario Tumino; Jarmo Virtamo; Stephanie J Weinstein; Meredith Yeager; Peter Kraft; Matthew L Freedman
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

Review 2.  [Diagnosis of the "aging male"--what is recommended?].

Authors:  V S Lenk
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 3.  Genetics of menstrual migraine: the molecular evidence.

Authors:  Natalie Colson; Francesca Fernandez; Lyn Griffiths
Journal:  Curr Pain Headache Rep       Date:  2010-10

4.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

5.  Androgen receptor CAG repeat polymorphism and hypothalamic-pituitary-gonadal function in Filipino young adult males.

Authors:  Calen P Ryan; Thomas W McDade; Lee T Gettler; Dan T A Eisenberg; Margarita Rzhetskaya; M Geoffey Hayes; Christopher W Kuzawa
Journal:  Am J Hum Biol       Date:  2016-07-15       Impact factor: 1.937

Review 6.  Depression in aging men: the role of testosterone.

Authors:  Ryan M Carnahan; Paul J Perry
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.

Authors:  Amelia Guadalupe-Grau; Francisco Germán Rodríguez-González; Jesús Gustavo Ponce-González; Cecilia Dorado; Hugo Olmedillas; Teresa Fuentes; Jorge Pérez-Gómez; Joaquín Sanchís-Moysi; Bonifacio Nicolás Díaz-Chico; José A L Calbet
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men.

Authors:  Stephen B Manuck; Anna L Marsland; Janine D Flory; Adam Gorka; Robert E Ferrell; Ahmad R Hariri
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

9.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.